Nephrol Dial Transplant (2003) 18: 2024-2031
© 2003 European Renal Association-European Dialysis and Transplant Association
Original Article
A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate
Departments of Clinical Chemistry and Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Correspondence and offprint requests to: Dr F. J. Hoek, Academic Medical Center, Department of Clinical Chemistry, Room F1-219, PO Box 22700, 1100 DE Amsterdam, The Netherlands. Email: f.j.hoek{at}amc.uva.nl
Background. In clinical practice, the glomerular filtration rate (GFR) is often estimated from plasma creatinine. Several studies have shown cystatin C (cys C) to be a better parameter for the diagnosis of impaired renal function. No data are available, however, on the performance of cys C in follow-up of patients, compared with creatinine. Also, comparisons of cys C with the Cockcroft and Gault (C&G) formula for estimation of GFR are few.
Methods. Plasma samples were obtained from 93 consecutive patients seen for GFR determination and from 30 patients with diabetes mellitus type 2, of whom 23 were investigated a second time after 2 years. GFR was determined with [125I]iothalamate. Plasma creatinine was determined enzymatically and the creatinine clearance calculated according to C&G. Cys C was measured with a particle-enhanced immunonephelometric method.
Results. GFR correlated with 1/cys C (r = 0.873) as well as with C&G (r = 0.876). The area under the curve (AUC) of the receiver operating curves (ROCs), a measure of diagnostic accuracy, for cys C (0.931) and C&G (0.938) were equal (P = 0.815) and both better than the creatinine AUC (0.848; P = 0.006). Bland and Altman analysis showed that the simple formula GFR = –4.32 + 80.35 x 1/cys C, derived from our data, gave more accurate (P < 0.0001) and more precise (P = 0.024) GFR estimates than obtained with the C&G formula. The day-to-day variation (biological +analytical) for cys C was small (3.1%, SD 2.51%) in diabetic patients. In the follow-up study in diabetic patients, cys C was the parameter which had the best correlation (r = 0.66) with changes in GFR.
Conclusions. Cys C shows a high correlation with GFR. With a very simple formula, cys C gives a good estimate of GFR, more accurate and precise than C&G. Because biological variation is low, cys C gives also a good assessment of GFR changes during follow-up. Cys C is the preferred endogenous parameter for GFR.
Keywords: Bland and Altman analysis; Cockcroft and Gault; creatinine; cystatin C; glomerular filtration rate; ROC analysis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Q.-P. Wang, J.-W. Gu, X.-H. Zhan, H. Li, and X.-H. Luo Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting Ann Clin Biochem, November 1, 2009; 46(6): 495 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bell, F. Granath, J. Martensson, E. Lofberg, A. Ekbom, C.-R. Martling, and of KING (Karolinska Intensive care Nephrology Grou Cystatin C is correlated with mortality in patients with and without acute kidney injury Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3096 - 3102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Al-Malki, P. A. Heidenheim, G. Filler, A. Yasin, and R. M. Lindsay Cystatin C Levels in Functionally Anephric Patients Undergoing Dialysis: The Effect of Different Methods and Intensities Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1606 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Boudville, M. Salama, G. P. Jeffrey, and P. Ferrari The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2926 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Alehagen, U. Dahlstrom, and T. L. Lindahl Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care Eur J Heart Fail, April 1, 2009; 11(4): 354 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Holweger, H.-P. Lipp, K. Dietz, J. T. Hartmann, and C. Bokemeyer Novel Algorithm for More Accurate Calculation of Renal Function in Adults with Cancer Ann. Pharmacother., December 1, 2008; 42(12): 1749 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ledson, M. L. P. Howse, N. B. Roberts, G. J. Kemp, and P. S. Williams Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria NDT Plus, June 1, 2008; 1(3): 194 - 195. [Full Text] [PDF]
|
|
|
|
|
|
M. Tidman, P. Sjostrom, and I. Jones Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients Nephrol. Dial. Transplant., March 1, 2008; 23(3): 1072 - 1073. [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hoek, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet Reply Nephrol. Dial. Transplant., March 1, 2008; 23(3): 1073 - 1073. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Baxmann, M. S. Ahmed, N. C. Marques, V. B. Menon, A. B. Pereira, G. M. Kirsztajn, and I. P. Heilberg Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin C Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tidman, P. Sjostrom, and I. Jones A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two Nephrol. Dial. Transplant., January 1, 2008; 23(1): 154 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Maahs, L. G. Ogden, A. Kretowski, J. K. Snell-Bergeon, G. L. Kinney, T. Berl, and M. Rewers Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes Diabetes, November 1, 2007; 56(11): 2774 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zahran, M. Qureshi, and A. Shoker Comparison between creatinine and cystatin C-based GFR equations in renal transplantation Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2659 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lassus, V.-P. Harjola, R. Sund, K. Siirila-Waris, J. Melin, K. Peuhkurinen, K. Pulkki, M. S. Nieminen, and for the FINN-AKVA Study group Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur. Heart J., August 1, 2007; 28(15): 1841 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Beauvieux, F. Le Moigne, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, H. Gin, and V. Rigalleau New Predictive Equations Improve Monitoring of Kidney Function in Patients With Diabetes Diabetes Care, August 1, 2007; 30(8): 1988 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease Ann Intern Med, July 3, 2007; 147(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, and J. Stessman Glomerular filtration rate estimation and mortality in an elderly population QJM, July 1, 2007; 100(7): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hoek, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1633 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Singh, M. A. Whooley, J. H. Ix, S. Ali, and M. G. Shlipak Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1087 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pucci, S. Triscornia, D. Lucchesi, C. Fotino, G. Pellegrini, E. Pardini, R. Miccoli, S. Del Prato, and G. Penno Cystatin C and Estimates of Renal Function: Searching for a Better Measure of Kidney Function in Diabetic Patients Clin. Chem., March 1, 2007; 53(3): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Perucca, N. Bouby, P. Valeix, and L. Bankir Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R700 - R705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Macdonald, S. M. Marcora, M. Jibani, G. Roberts, M. J. Kumwenda, R. Glover, J. Barron, and A. B. Lemmey Bioelectrical impedance can be used to predict muscle mass and hence improve estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3481 - 3487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Brosius III, T. H. Hostetter, E. Kelepouris, M. M. Mitsnefes, S. M. Moe, M. A. Moore, S. Pennathur, G. L. Smith, and P. W.F. Wilson REPRINT Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease: A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation Hypertension, October 1, 2006; 48(4): 751 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Brosius III, T. H. Hostetter, E. Kelepouris, M. M. Mitsnefes, S. M. Moe, M. A. Moore, S. Pennathur, G. L. Smith, and P. W.F. Wilson Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease: A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation Circulation, September 5, 2006; 114(10): 1083 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1855 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Poge, T. Gerhardt, B. Stoffel-Wagner, H. U. Klehr, T. Sauerbruch, and R. P. Woitas Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients Nephrol. Dial. Transplant., March 1, 2006; 21(3): 660 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, A. Cohen, and J. Stessman Moderate renal insufficiency at 70 years predicts mortality QJM, February 1, 2006; 99(2): 97 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Grubb and J. Bjork Errors in the Assessment of Estimated Glomerular Filtration Rate: Reply Clin. Chem., January 1, 2006; 52(1): 154 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 C. White, A. Akbari, N. Hussain, L. Dinh, G. Filler, N. Lepage, and G. A. Knoll Estimating Glomerular Filtration Rate in Kidney Transplantation: A Comparison between Serum Creatinine and Cystatin C-Based Methods J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3763 - 3770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Risch, H. Drexel, and A. R. Huber Differences in Glomerular Filtration Rate Estimates by 2 Cystatin C-Based Equations Clin. Chem., November 1, 2005; 51(11): 2211 - 2212. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Huber and L. Risch Recent Developments in the Evaluation of Glomerular Filtration Rate: Is There a Place for {beta}-Trace? Clin. Chem., August 1, 2005; 51(8): 1329 - 1330. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Sear Kidney dysfunction in the postoperative period Br. J. Anaesth., July 1, 2005; 95(1): 20 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Stevens and A. S. Levey Chronic Kidney Disease in the Elderly -- How to Assess Risk N. Engl. J. Med., May 19, 2005; 352(20): 2122 - 2124. [Full Text] [PDF]
|
|
|
|
|
|
B. A. Perkins, R. G. Nelson, B. E.P. Ostrander, K. L. Blouch, A. S. Krolewski, B. D. Myers, and J. H. Warram Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C Concentration: Results of a 4-Year Follow-Up Study J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1404 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoppe, S. Seronie-Vivien, F. Thomas, J.-P. Delord, L. Malard, P. Canal, and E. Chatelut Serum Cystatin C is a Better Marker of Topotecan Clearance than Serum Creatinine Clin. Cancer Res., April 15, 2005; 11(8): 3038 - 3044. [Abstract] [Full Text] [PDF]
|
|